chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches after 3rd dose), PYREXIA (High temperature after 3rd dose), HEADACHE (Terrible headache after 3rd dose) and INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 non-Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches after 3rd dose), PYREXIA (High temperature after 3rd dose), HEADACHE (Terrible headache after 3rd dose) and INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 non-Moderna COVID-19 vaccine). On 20-Nov-2021, INTERCHANGE OF VACCINE PRODUCTS (Dose 1 and 2 non-Moderna COVID-19 vaccine) had resolved. At the time of the report, FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches after 3rd dose), PYREXIA (High temperature after 3rd dose) and HEADACHE (Terrible headache after 3rd dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.No concomitant medications reported.No treatment reported. This case was linked to MOD-2021-395575 (Patient Link).
patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 7 patients. This report is for 1st of 7 patient.   A patient of unspecified age and gender received the first dose of bnt162b2 (BNT162B2 also reported as Pfizer Covid vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on an unspecified date at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer reported that 7 coworkers was tested positive for Covid after receiving first dose of the Pfizer Covid vaccine on an unspecified date. The outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : 2021045638 same drug/AE, different patient;2021045639 same drug/AE, different patient;2021045643 same drug/AE, different patient;2021045641 same drug/AE, different patient;2021045642 same drug/AE, different patient;2021045640 same drug/AE, different patient;US-PFIZER INC-2021045639 same drug/AE, different patient
Vaccine administered after 12 hours. (Vial was first punctured on 1/4/22 at 8:18am. Vaccine was given at 1:09pm on 1/5/22.) No adverse reaction.
Raised, red, itchy rash at injection site - 6in long, full width of upper arm (appeared 24 hrs after injection, lasted 9 days), sharp stabbing headache (lasted 48 hours), dizziness (started almost immediately, lasted 4 days), chills (lasted 48 hours), low-grade fever (lasted 24 hours), aches at all joints (lasted 24 hours), tired (slept most of 36 hours following injection, starting 12 hrs after injection)
My menstrual cycles have been a regular 28 day cycle  within a 1-2 day margin of difference for 29 years, even through times of illness, stress, travel, etc.  After the second shot of Moderna my period came 6 days early and much heavier than normal.  My period returned to my normal 28 day cycle again the next month.  This threw off the timing of a breast MRI though (tied to menstrual cycle) and was concerning as this was not a side effect on my radar
Information has been received from a physician concerning a 4 month old female patient, with no pertinent medical history and no known drug allergies, who on 22-DEC-2009, was vaccinated with a first dose of ROTATEQ (dose, route and lot number not provided). On 03-MAR-2010, the patient received orally the second "0.2 mL" dose of ROTATEQ (lot number 664874/1213Y). Another vaccines administered on the same day included PENTACEL and PREVNAR. Concomitant therapy included an antibiotic (not specified) for the strep throat. On 03-MAR-2010, the patient was admitted in the hospital for intussusceptions after getting ROTATEQ. The physician stated that on 03-MAR-2010, the first symptoms appeared in the form of non-bilious vomiting, not eating, and malaise. Later that day, the patient was taken to the emergency room at the hospital. No computed axial tomography scans or ultrasounds were performed, as it was initially thought the patient had gastroenteritis. There were no bloody stools. Patient was admitted and treated with IV fluids. On 04-MAR-2010, examination showed abdominal tenderness and an unsuccessful barium enema was done. On the same day, the patient had surgery where the intussusception was manually reduced. No predisposing conditions. After surgery, the patient was doing better. The baby was full term. At the time of reporting, the patient had recovered. The physician considered intussusceptions to be disabling and life threatening. No further information is available. On 03-MAR-2010, the patient was admitted in the hospital.
1-2 days after ROTATEQ developed gagging esp. when eating, vomiting, diarrhea lost 8 oz. within 5 days of administration of ROTATEQ.
Eight days after injection,  I noticed a red lump, warm to the touch at injection site. No pain
Arthus reaction: edema, erythema, warm to touch, 3/10 pain.
Injection site - red, hot, swollen, ache, fever and chills - 9-3-14. Tachycardia and irregular heart rate - 9-5-14 and continues through 9-25-14.
Violent reaction next am-Emergency visit to Dr.- 11/16/08 next day -Saline-2lts antibiotic drip -No improvement-refer to hospital -Patient sensed imminent death-very ill. 3-31-08 Patient to undergo-Liver Biopsy, -Bone marrow same -still symptomatic 4-1-08.  4/8/08 Case closed w/records that accompanied report.   DX 11/21/07: UTI, dehydration, weakness Records reveal patient experienced nausea, diarrhea & fatigue x 5 days when seen in ER on 11/21/2007.  Had been dx w/UTI on 11/18/07 & was taking Cipro.  Had severe sweating & chills 11/20/07.   Returned to ER 11/27/2007 & admitted 11/27-11/29/2007.   DX 11/27/07: acute cholecystitis, hepatitis & sepsis. Presented w/nausea, vomiting, poor appetite, intermittent fevers, soaking night sweats, urinary incontinence, tender RUQ & epigastrum where liver easily palpable & tender.  Feeling unwell x 2 weeks.  Had significant weight loss over past year.   GI consult done & EGD/colonoscopy done.  Office notes from 12/12/2007-2/19/2008. PCP FINAL Dx: viral sepsis secondary to shingles vaccine. Records reveal repeat labs improved.  Exam on 12/27 WNL w/heart murmur.  PCP felt patient septic from shingles vaccine.  Started on megace to improve appetite 1/14/08 although clinically she felt much improved.
angioedema responsive to antihistamines and steroids,  discharged from ED after 3 hours.
Patient presented at the pharmacy on October 23, 2008 complaining of some redness and swelling near injection site about 4 inches in length and 2 inches in width. The patient was advised to continue applying cold compresses to area and instructed by the RPH to use and OTC antihistamine. The area was marked placing for dots at each corner and the patient was informed that if the area continued to grow, to contact her physician or ER immediately. VAERS completed. Patient was advised if any further problems, either contact PCP or visit ER. Documentation added to person's allergy profile.
Arm that got injection is very sore. Muscle aches, headache, and fever of 99.8. Started about 12 hours after injection. Tylenol helps with symptoms.
Information has been received from a registered nurse concerning a 6 month old patient (unknown gender) who in approximately May 2009 at 12 week old, was vaccinated with the first dose of ROTATEQ (lot number and route not reported). On 13-AUG-2009 the patient was at the office to receive the second dose of ROTATEQ (lot number and route not reported). No adverse reactions reported. Additional information has been requested.
(Registered Nurse)    Pt reports a rash developed the next day after receiving her first Pfizer vaccine, occurring across her midsection of abdomen. It lasted for 2 weeks. No other problems with the vaccination. Reports that her physician recommended that she continue with second dose as scheduled.
On December 28th I was traveling and my hand started to itch, and my beard was scratchy, in the evening I realized I had hives all over my hands, I took some generic Benadryl, in the morning the hives got worse they spread to all over my body almost every place that I touched with my hands on my skin. I had a small fever 100.2   I got prescription medicine to deal with an allergic reaction from an e doctor and urgent care, hives on the body subsided but my hands are still inflamed and very itchy/scratchy
Tested positive for COVID-19 01/04/2022. My symptoms was mild, I mainly had a cough, I was very tired, some mucus and some chills. I never had any fever.
We had a COVID 19 vaccine clinic that was held on 01/27/21. We had an employee who was given a first dose of the vaccine in December 2020, and was 17 years old. The employee had a signed consent from her mother who is a ED nurse. The employee had no adverse reaction from the vaccine, and she and her mother wanted the vaccine series completed. She was given her second dose of Moderna vaccine on 01/27/21 at 10:45am, or the dose would have been wasted.  Patient has not reported any adverse symptoms except pain in her left deltoid where the immunization was given.
pt recieved both vaccine on left arm where she got her lymph node removal. She reported to have redness spread like a size of a dollar bill located insert side of left arm. Pt had consulted doctor to monitor if redness continue spreading by drawing lines. Pt have no other syptoms other than redness.
Information has been received from an administrator, referring to a 13 year old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. The reporter stated that, in approximately September 2016 (reported as 6 months ago) the patient received a dose of CERVARIX (strength, dose, anatomical location, lot number and expiration date were not reported) and on 07-MAR-2017, she received a dose of GARDASIL 9 lot # M035486 with an expiration date on 05-JUN-2019 (strength, dose, anatomical location and administration route were not reported) for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
23yo present passing out after getting two Imminization and lying for 5mins after standing up he felt nausea and passed out. TX: pt put on C spine and 4 men lift unto guerney and transported to Xray for Cleared C spine Based and no evidence of fractures and plain film.
99.7F fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (99.7F fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (99.7F fever). At the time of the report, PYREXIA (99.7F fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
C/o dizzy, drowsy, felt like going to faint. Also c/o hot. Denies SOA, no rash. Also c/o stomach pain, legs hurting monitored. Called parent per childs request to pick up.
1/9/2021 experienced significant pain at injection site, by 1/10/2021 AM pain had mostly subsided to a level normally associated with vaccines. 1/10/2021 in the morning began experiencing mild intermittent numbness in left hand. 1/10/2021 afternoon began experiencing extreme low back pain when standing and walking. Cannot tie any of these symptoms to other causes. Back pain and hand numbness still present at 5 PM 1/10/2021.
Temp. 102 next day. Had diarrhea and vomiting 2 weeks later broke out in a red-purple rash.  Required benadryal and cortisone cream (prescribed by family doctor) Now has bilateral ear infection and still has rash.
First dose- sore arm, chills on day 2 Second dose- increased heart rate 15-20 minutes after injection, nausea, and hot flashes 30 minutes-7 hours after injection. Around 6:30 pm body spasms began (they were more rapid and out of sync than normal cold/flu shaking) with extreme dehydration. At 7:30-8pm a fever set in at 101.0, body continued to have shakes/spasms, nausea still around, aching joints, and blood system felt extremely warm as if hot water was flowing through veins/arteries. Next morning fever spiked to 102.7 and stuck on until 48 hours later. Nausea, vomiting, and diarrhea kept staying for about a week.
9 days after the vaccine dose she woke up with small liquid cell blisters over lips, groin, armpits, torso, itched and painful as the days went on, got more painful, spread to throat, tongue and mouth by 9/15, could not eat or swallow, lost 15 pounds.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a adult male patient who received ENGERIX B adult (batch number Z25GH, expiry date 6th March 2019). Previously administered products included ENGERIX-B adult (1st dose received on an unknown date) and ENGERIX-B adult (2nd dose received on an unknown date). On 25th October 2016, the patient received 3rd dose of ENGERIX B adult. On 25th October 2016, immediately after receiving ENGERIX B adult, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to ENGERIX B adult. Additional details were provided as follows: The age at vaccination was not reported. Six months after the last or 3rd dose of ENGERIX B adult, the patient was complaining of soreness or tenderness of right deltoid (injection site). As per the patient, this reaction occurred immediately following the 3rd dose of ENGERIX-B adult but he did not complain of it because he thought the side effect would wane. The patient was complaining that the soreness or tenderness at the injection site did not wane and he was still experiencing it at the time of reporting.
This spontaneous report as received from a healthcare worker refers to a unspecified number of patient of unknown age and gender. On an unknown date, the patients were vaccinated with M-M-R II (dose, route and Lot# not reported) which underwent supported temperature excursions. No adverse experiences were reported. This is one of several reports from the same source. Additional information has been requested.
Sore throat, SOB, vomiting, cough, body aches, chest pain, headache, loss of appetite, congestion.  No thermometer so unknown if she has a fever.  Onset 12/27 and tested positive 12/28.  Exposure likely occurred at a gathering on 12/24.
Self test positive for Covid 19 twice on 08Apr2022/Tested positive at doctor office on 08Apr2022; Self test positive for Covid 19 twice on 08Apr2022/Tested positive at doctor office on 08Apr2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 67-year-old male patient received BNT162b2 (BNT162B2), on 22Oct2021 at 10:30 as dose 3 (booster), single (Lot number: 32030BD) at the age of 67 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "drug allergy" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN, start date: 01Jan2017, stop date: 07Apr2022.  The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 07Apr2022, outcome "recovered" (25Apr2022) and all described as "Self test positive for Covid 19 twice on 08Apr2022/Tested positive at doctor office on 08Apr2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Apr2022) Positive, notes: Self test positive for Covid 19 and at doctor office; (25Apr2022) Negative, notes: Self test. Therapeutic measures were taken as a result of covid-19, drug ineffective as patient received Paxlovid for the treatment of COVID-19 from 09Apr2022 to 13Apr2022. The patient did a self test which was positive for Covid 19 twice on 08Apr2022 and Tested positive at doctor office on 08Apr2022. The symptoms fatigue and sore throat began on 07Apr2022. Began fever on 09Apr2022. Began Paxlovid prescription on 09Apr2022 and completed 5 days series on 13Apr2022. Felt good on 12Apr2022. After 5 days isolated and no symptoms per CDC, went to retail store, all wearing mask, and one restaurant on 17Apr2022. Woke up on 18Apr2022 with significant cold like symptoms. Contacted doc for guidance and was not instructed to take Covid test. Instructed to treat symptoms and report if anything changed. For next 5 days, had Covid like symptoms but different from first round symptoms like low fever, tired, runny nose, congestion. Started feeling a little better after about another 5 days. No further Covid testing done after 08Apr2022 until 25Apr2022 self test which was negative. No Hospitalization or prolongation. No Known allergies.
presents to ED for evaluation of shortness of breath. Pt states she missed dialysis yesterday because she was "too sick". She reports a 9lb weight gain since her Thursday treatment.  She reports abdominal pain and constipation as the reason she did not go to dialysis. She also complains of nausea, peripheral edema, and fatigue
patient received COVID booster. left and went home. He returned around 215ish and stated he had experienced an adverse rxn to the shot. He said after about one hour after the shot he was sitting at the computer and became "daze" and confused and felt like he was going to pass out. He says he experiences this when his sugar goes "too low". He had to call for his dad and ate some candy. After about 10 minutes, the feeling begins to pass. He did not know his "sugar levels" before or after the event. He weighs approximately 180 pounds. He came into the store to let me know because he knows "we" keep up with these things.
Pt w/hx of dementia brought to ED w/fevers and low oxygen saturation and worsening SOB and lethargic. CXR showed chronic appearing interstitial prominence and left basilar opacity. Pt was found to be positive of COVID-19 infection. Had received both Moderna vaccines (1/19/21 & 2/16/21). Pt admitted for additional management for acute hypoxemic respiratory failure, COVID-19 pneumonia and treated with dexamethasone, combivent nebs, remdesivir, and azithromycin/ceftriaxone empirically for secondary bacterial pneumonia. Pt ultimately was discharged 3 days later to an assisted living facility where she resides oxygenating well and more alert.
Dimple @ site of injection. Left thigh.   Dimple increased in size over the next 6 months.   Dimple is now the size of a dime.
12/5/05 swelling immediately following administration seen in ER, where parent is a nurse and given Benadryl.  12/7/05 mild swelling to upper arm.  12/13/05 presented with hives & shortness of breath.  Rx: SoluMedrol 125mg, Benadryl 50mg IM, Albutrelol
Information has been received from a registered nurse concerning unspecified patients of unknown age and gender. On an unknown date, unspecified patients were vaccinated with multiple doses of PROQUAD (Merck) (0.5 ml, subcutaneous) which were all post supported temperature excursion. No adverse effects were reported by any patient. This is one of the several reports from the same reporter. (Linked to MARRS# 1502USA006586). Additional information has been requested.
This spontaneous report as received from a nurse refers to a 65 year old male patient. In approximately 2009 (reported as 'approximately 5 years ago') the patient was vaccinated with his first dose of GARDASIL (dose and route of administration were not reported, unknown lot number and expiration date). Concomitant medications were not reported. The nurse called for recommendations for 2nd dosing of GARDASIL to a gentleman who received his first dose approximately 5 years ago, but then reported that the gentleman was currently 65 years old. It was reported that she quickly added that he was not their patient 5 years ago and she was not sure he was actually administered suspected medication and that he might be confused. No adverse effects were noted to patient. Additional information has been requested.
States she had fever, did not take temp but reports chills and felt she had fever. Heat swelling redness to area. Pain at site. Flu like symptoms felt delusional.  Symptoms started in evening.
patient had previously received J$J vaccine at the hospital, he came in 07/27/2021 and told us he needed to get his covid vaccine, patient filled up the questionnaire and indicated on it that he had never received a covid vaccine. the pharmacist ended up giving the patient his first dose of pfizer, and on 08/24-2021 patient came in to receive the 2nd dose of pfizer.  On 09/21/21, the nurse called from the hospital to inform us about the patient had already received a J$J vaccine in the past. So we ended up documenting and reported the issue to the hospital
Dizziness/itching resolved in 30 mins Numbness: left arm and face resolved 4 hrs
Tinnitus, brain fog, pressure in ears for 4 days. Mucinex resolved the issue.
had awful chills all night; flu like headache; flu like headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (COMIRNATY), on 09Jan2021 as dose 1, single (Lot number: EL3247) at the age of 69 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "sensitive to drugs" (unspecified if ongoing), notes: She is sensitive to drugs; "cholesterol" (unspecified if ongoing), notes: her cholesterol medication they have her on. The patient took concomitant medications. Past drug history included: Benadryl, reaction(s): "allergic to Benadryl". The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), HEADACHE (non-serious) all with onset 09Jan2021, outcome "recovered" (11Jan2021) and all described as "flu like headache"; CHILLS (non-serious) with onset 09Jan2021, outcome "recovered" (11Jan2021), described as "had awful chills all night". Additional information: Within 10 minutes, the patient had awful chills all night. She also had flu like headache and all that type for 3 days. Trying to contact primary doctor and didn't hear so scheduled 2nd one. She had the 2 main vaccines of Pfizer.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300250669 Same patient/product; different dose/events;US-PFIZER INC-202300250670 Same patient/product; different dose/events;
03/11/22 presents to ED for "Shortness of breath". PMHx of "htn, hypothyroidism, breast cancer recurrence and metastasis".